127 related articles for article (PubMed ID: 34606672)
21. Analytical validation and clinical application of urinary vanillylmandelic acid and homovanillic acid by LC-MS/MS for diagnosis of neuroblastoma.
Shen Y; Li H; Lu J; Luo X; Guan Q; Cheng L
Biomed Chromatogr; 2019 Jun; 33(6):e4484. PubMed ID: 30632178
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factor in neuroblastoma.
Evans AE; D'Angio GJ; Propert K; Anderson J; Hann HW
Cancer; 1987 Jun; 59(11):1853-9. PubMed ID: 3567848
[TBL] [Abstract][Full Text] [Related]
23. [A preliminary study of retinoblastoma-related serum tumor markers].
Liu ZP; Zhou KY; Chen LL; Xiao ZH; Chen YZ
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Mar; 19(3):318-321. PubMed ID: 28302204
[TBL] [Abstract][Full Text] [Related]
24. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group.
Zeltzer PM; Marangos PJ; Parma AM; Sather H; Dalton A; Hammond D; Siegel SE; Seeger RC
Lancet; 1983 Aug; 2(8346):361-3. PubMed ID: 6135871
[TBL] [Abstract][Full Text] [Related]
25. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
Tuchman M; Ramnaraine ML; Woods WG; Krivit W
Pediatrics; 1987 Feb; 79(2):203-5. PubMed ID: 3808793
[TBL] [Abstract][Full Text] [Related]
26. Urinary homovanillic and vanillylmandelic acid in the diagnosis of neuroblastoma: report from the Italian Cooperative Group for Neuroblastoma.
Barco S; Gennai I; Reggiardo G; Galleni B; Barbagallo L; Maffia A; Viscardi E; De Leonardis F; Cecinati V; Sorrentino S; Garaventa A; Conte M; Cangemi G
Clin Biochem; 2014 Jun; 47(9):848-52. PubMed ID: 24769278
[TBL] [Abstract][Full Text] [Related]
27. [Value of 123I-MIBG scanning, neuron-specific enolase and serum ferritin in the diagnosis and follow-up of patients with neuroblastoma].
Hervás Benito I; Rivas Sánchez A; Bello Arques P; Cañete A; Fernández JM; Saura Quiles A; González Cabezas P; Ruiz Rodríguez JC; Castell V; Pérez Pastor JL; Monfort JA; Mateo Navarro A
Rev Esp Med Nucl; 2001 Aug; 20(5):369-76. PubMed ID: 11470071
[TBL] [Abstract][Full Text] [Related]
28. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
Jpn J Clin Oncol; 1990 Sep; 20(3):268-70. PubMed ID: 2255102
[TBL] [Abstract][Full Text] [Related]
29. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
Li CS; Cheng BC; Ge W; Gao JF
Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous measurement of VMA and HVA in 24-hour urine samples.
Harr R
Clin Lab Sci; 1991; 4(4):237-41. PubMed ID: 10149424
[TBL] [Abstract][Full Text] [Related]
31. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
Isgrò MA; Bottoni P; Scatena R
Adv Exp Med Biol; 2015; 867():125-43. PubMed ID: 26530364
[TBL] [Abstract][Full Text] [Related]
32. Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results?
Sies CW; Florkowski CM; Sullivan M; Mackay R; George PM
Ann Clin Biochem; 2006 Jul; 43(Pt 4):300-5. PubMed ID: 16824281
[TBL] [Abstract][Full Text] [Related]
33. Determination of serum catecholamine metabolites in neuroblastoma by high performance liquid chromatography with electrochemical detection.
Tang QM; Xu XR; Shi YQ; Jin BX
Biomed Chromatogr; 1986 Feb; 1(1):7-11. PubMed ID: 3506818
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of catecholamine excretion levels in diagnosis and treatment of neuroblastoma.
Bond JV
Arch Dis Child; 1975 Sep; 50(9):691-5. PubMed ID: 1190818
[TBL] [Abstract][Full Text] [Related]
35. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.
Tonini GP; Boni L; Pession A; Rogers D; Iolascon A; Basso G; Cordero di Montezemolo L; Casale F; Pession A; Perri P; Mazzocco K; Scaruffi P; Lo Cunsolo C; Marchese N; Milanaccio C; Conte M; Bruzzi P; De Bernardi B
J Clin Oncol; 1997 Jan; 15(1):85-93. PubMed ID: 8996128
[TBL] [Abstract][Full Text] [Related]
36. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
Cangemi G; Barco S; Reggiardo G; Viscardi E; Di Cataldo A; Garaventa A; Melioli G; Conte M
Pediatr Blood Cancer; 2013 Dec; 60(12):E170-2. PubMed ID: 23813598
[TBL] [Abstract][Full Text] [Related]
37. Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.
Georgantzi K; Sköldenberg EG; Stridsberg M; Kogner P; Jakobson Å; Janson ET; Christofferson RHB
Pediatr Hematol Oncol; 2018 Mar; 35(2):156-165. PubMed ID: 29737901
[TBL] [Abstract][Full Text] [Related]
38. Serum neuron-specific/nonneuronal enolase ratio in the diagnosis of neuroblastomas.
Viallard JL; Tiget F; Hartmann O; Lemerle J; Demeocq F; Malpuech G; Dastugue B
Cancer; 1988 Dec; 62(12):2546-53. PubMed ID: 3191453
[TBL] [Abstract][Full Text] [Related]
39. Urinary dopamine/noradrenaline and dopamine/vanillylmandelic acid ratios as a reflection of different biology of adrenergic clones in children's neuroblastic tumors.
Izbicki T; Bozek J; Perek D; Wozniak W
J Pediatr Surg; 1991 Oct; 26(10):1230-4. PubMed ID: 1779334
[TBL] [Abstract][Full Text] [Related]
40. Application of an LC-MS/MS Method for the Simultaneous Quantification of Homovanillic Acid and Vanillylmandelic Acid for the Diagnosis and Follow-Up of Neuroblastoma in 357 Patients.
Hwang N; Chong E; Oh H; Cho HW; Lee JW; Sung KW; Lee SY
Molecules; 2021 Jun; 26(11):. PubMed ID: 34200415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]